In this uncontrolled, non-randomized, prospective, local post-marketed surveillance study,
data are obtained on safety and efficacy of LEVITRA® in routine treatment of erectile
dysfunction. The general objectives are to evaluate the product safety (primarily by
recording adverse events), efficacy and patient acceptance.